Linc AB (STO:LINC)

Market Cap	3.93B
Revenue (ttm)	1.29B
Net Income (ttm)	1.30B
Shares Out	57.91M
EPS (ttm)	22.48
PE Ratio	3.02
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	97,592
Average Volume	211,428
Open	67.50
Previous Close	67.50
Day's Range	67.20 - 68.10
52-Week Range	59.70 - 103.40
Beta	0.88
RSI	39.77
Earnings Date	Apr 17, 2025

About Linc AB

Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million ($2.99 million) and SEK 250 million ($29.9...

• Industry: Asset Management
• Sector: Financials
• Founded: 1991
• Employees: 2
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: LINC

Financial Performance

In 2024, Linc AB's revenue was 1.29 billion, an increase of 95.80% compared to the previous year's 659.45 million. Earnings were 1.30 billion, an increase of 110.12%.